ArticleDrug design, development and therapy2018

Self-nanomicellizing solid dispersion of edaravone: part II: in vivo assessment of efficacy against behavior deficits and safety in Alzheimer's disease model.

Ankit Parikh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.